362 related articles for article (PubMed ID: 29907739)
1. Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy.
Ni K; Lan G; Chan C; Quigley B; Lu K; Aung T; Guo N; La Riviere P; Weichselbaum RR; Lin W
Nat Commun; 2018 Jun; 9(1):2351. PubMed ID: 29907739
[TBL] [Abstract][Full Text] [Related]
2. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
3. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
Lu K; He C; Guo N; Chan C; Ni K; Lan G; Tang H; Pelizzari C; Fu YX; Spiotto MT; Weichselbaum RR; Lin W
Nat Biomed Eng; 2018 Aug; 2(8):600-610. PubMed ID: 31015630
[TBL] [Abstract][Full Text] [Related]
4. Nanoscale Metal-Organic Framework Mediates Radical Therapy to Enhance Cancer Immunotherapy.
Ni K; Aung T; Li S; Fatuzzo N; Liang X; Lin W
Chem; 2019 Jul; 5(7):1892-1913. PubMed ID: 31384694
[TBL] [Abstract][Full Text] [Related]
5. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
Zeng JY; Zou MZ; Zhang M; Wang XS; Zeng X; Cong H; Zhang XZ
ACS Nano; 2018 May; 12(5):4630-4640. PubMed ID: 29584395
[TBL] [Abstract][Full Text] [Related]
6. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
Lu K; He C; Guo N; Chan C; Ni K; Weichselbaum RR; Lin W
J Am Chem Soc; 2016 Sep; 138(38):12502-10. PubMed ID: 27575718
[TBL] [Abstract][Full Text] [Related]
7. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.
Olivo Pimentel V; Marcus D; van der Wiel AM; Lieuwes NG; Biemans R; Lieverse RI; Neri D; Theys J; Yaromina A; Dubois LJ; Lambin P
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33688020
[TBL] [Abstract][Full Text] [Related]
8. Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework.
Ni K; Xu Z; Culbert A; Luo T; Guo N; Yang K; Pearson E; Preusser B; Wu T; La Riviere P; Weichselbaum RR; Spiotto MT; Lin W
Nat Biomed Eng; 2022 Feb; 6(2):144-156. PubMed ID: 35190678
[TBL] [Abstract][Full Text] [Related]
9. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
Qin Y; Vasilatos SN; Chen L; Wu H; Cao Z; Fu Y; Huang M; Vlad AM; Lu B; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2019 Jan; 38(3):390-405. PubMed ID: 30111819
[TBL] [Abstract][Full Text] [Related]
11. Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.
Zheng W; Skowron KB; Namm JP; Burnette B; Fernandez C; Arina A; Liang H; Spiotto MT; Posner MC; Fu YX; Weichselbaum RR
Oncotarget; 2016 Jul; 7(28):43039-43051. PubMed ID: 27343548
[TBL] [Abstract][Full Text] [Related]
12. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
Hu ZI; Ho AY; McArthur HL
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141
[TBL] [Abstract][Full Text] [Related]
13. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8
Wang H; Lin X; Luo Y; Sun S; Tian X; Sun Y; Zhang S; Chen J; Zhang J; Liu X; Liu H; Gong Y; Xie C
Immunotherapy; 2019 Feb; 11(2):101-118. PubMed ID: 30511887
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment.
Luo R; Firat E; Gaedicke S; Guffart E; Watanabe T; Niedermann G
Clin Cancer Res; 2019 Dec; 25(23):7243-7255. PubMed ID: 31506388
[TBL] [Abstract][Full Text] [Related]
15. Combination low-dose cyclophosphamide with check-point blockade and ionizing radiation promote an abscopal effect in mouse models of melanoma.
Luo X; Zeng M
J Cancer Res Ther; 2024 Apr; 20(2):718-725. PubMed ID: 38687945
[TBL] [Abstract][Full Text] [Related]
16. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8
Walker JM; Rolig AS; Charych DH; Hoch U; Kasiewicz MJ; Rose DC; McNamara MJ; Hilgart-Martiszus IF; Redmond WL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457127
[TBL] [Abstract][Full Text] [Related]
17. Metal-ligand coordination nanomaterials for radiotherapy: emerging synergistic cancer therapy.
Zeng L; Cao Y; He L; Ding S; Bian XW; Tian G
J Mater Chem B; 2021 Jan; 9(2):208-227. PubMed ID: 33215626
[TBL] [Abstract][Full Text] [Related]
18. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant
Oba T; Kajihara R; Yokoi T; Repasky EA; Ito F
Cancer Res; 2021 Dec; 81(24):6183-6195. PubMed ID: 34666993
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework.
Ge YX; Zhang TW; Zhou L; Ding W; Liang HF; Hu ZC; Chen Q; Dong J; Xue FF; Yin XF; Jiang LB
Biomaterials; 2022 Mar; 282():121407. PubMed ID: 35217343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]